The results from this study are novel as we have been able to compare and contrast the views of women across the BC risk continuum from women with previously identified BRCA1 and BRCA2 pathogenic variants in the FCC setting, to those participating in the Australian NBSP, BreastScreen Australia, recruited through LifePool. The gene discussed is BRCA2; the disease is breast cancer.